Saudi Arabia’s Healthcare Sectors Thrive Through Collaborations with US Companies
In a bid to boost its food, drug, medical devices, and equipment sectors, Saudi Arabia is engaging in fruitful meetings with US healthcare firms to explore investment opportunities between the two countries.
According to the Saudi Press Agency, the CEO of the Saudi Food and Drug Authority, Hisham bin Saad Aljadhey, recently met with officials from American companies on the sidelines of the 25th session of the International Medical Device Regulators Forum in Washington DC.
This move is part of SFDA’s efforts to enhance funding opportunities, delve into industry dynamics, and address challenges faced by investors and the business community.
The organization’s primary mission is to ensure public health by guaranteeing the quality, efficacy, and accessibility of both human and veterinary medicines and essential products.
Discussions also revolved around supporting the private sector in Saudi Arabia, particularly in areas related to drug localization, pharmaceutical industries, food safety, and genetics technologies.
The advancement in Saudi healthcare was evident in February when US-based Johnson & Johnson’s technology firm, J&J MedTech KSA, launched direct operations in the Kingdom. The company aims to provide customers with high-tech medical and surgical equipment for improved clinical outcomes.
Furthermore, drug production in Saudi Arabia is set to receive a boost following the signing of agreements in January to enhance partnerships between the public and private sectors. The agreements focus on industry localization and knowledge transfer to enhance health and pharmaceutical security in the country.